Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$857K Buy
2,561
+756
+42% +$240K 0.01% 399
2026
Q1
$452K Buy
+1,805
New +$401K ﹤0.01% 514
2023
Q4
Sell
-9,398
Closed -$350K 797
2023
Q3
$350K Sell
9,398
-4,947
-34% -$163K ﹤0.01% 537
2023
Q2
$355K Sell
14,345
-55
-0.4% -$944 ﹤0.01% 547
2023
Q1
$206K Buy
14,400
+313
+2% +$4.59K ﹤0.01% 726
2022
Q4
$192K Buy
14,087
+194
+1% +$2.59K ﹤0.01% 710
2022
Q3
$135K Buy
13,893
+38
+0.3% +$427 ﹤0.01% 685
2022
Q2
$114K Hold
13,855
﹤0.01% 693
2022
Q1
$194K Buy
13,855
+4,490
+48% +$79.8K ﹤0.01% 732
2021
Q4
$234K Sell
9,365
-2,310
-20% -$57.8K ﹤0.01% 678
2021
Q3
$281K Hold
11,675
﹤0.01% 600
2021
Q2
$319K Hold
11,675
﹤0.01% 551
2021
Q1
$234K Hold
11,675
﹤0.01% 638
2020
Q4
$218K Hold
11,675
﹤0.01% 574
2020
Q3
$202K Hold
11,675
﹤0.01% 522
2020
Q2
$158K Hold
11,675
﹤0.01% 523
2020
Q1
$101K Buy
+11,675
New +$129K ﹤0.01% 461

Other funds holding VRT

Greenleaf Trust's VRT Position: Q2 2026 in Review

Greenleaf Trust increased its Vertiv (VRT) stake by 42% in Q2 2026, buying an estimated $240K and bringing the position to 2,561 shares worth $857K. The position accounts for 0.01% of the portfolio, ranked #399.

Greenleaf Trust first reported a position in VRT in Q1 2020 and has held it in 17 quarters since. 2,052 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • Greenleaf Trust held 2,561 shares of Vertiv worth $857K as of Q2 2026.
  • Greenleaf Trust bought 756 Vertiv shares in Q2 2026, an estimated $240K.
  • Vertiv made up 0.01% of Greenleaf Trust's portfolio in Q2 2026, its #399 holding.
  • Greenleaf Trust first reported a position in Vertiv in Q1 2020 and has held it in 17 quarters since.
  • 2,052 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.